BIOMARIN PHARMACEUTICAL INC Insider Trading for March 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC for March 2016.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Option Exercise | A | 83.43 | 34,270 | 2,859,146 | 34,270 | |
Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Grant | A | 0.00 | 15,290 | 0 | 91,480 | 76.2 K to 91.5 K (+20.07 %) |
Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | A | 83.43 | 136,050 | 11,350,652 | 136,050 | |
Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 0.00 | 60,710 | 0 | 392,221 | 331.5 K to 392.2 K (+18.31 %) |
Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Option Exercise | A | 83.43 | 37,290 | 3,111,105 | 37,290 | |
Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 0.00 | 16,640 | 0 | 63,933 | 47.3 K to 63.9 K (+35.18 %) |
Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Option Exercise | A | 83.43 | 36,280 | 3,026,840 | 36,280 | |
Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Grant | A | 0.00 | 16,190 | 0 | 138,626 | 122.4 K to 138.6 K (+13.22 %) |
Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Option Exercise | A | 83.43 | 44,340 | 3,699,286 | 44,340 | |
Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Grant | A | 0.00 | 19,790 | 0 | 120,666 | 100.9 K to 120.7 K (+19.62 %) |
Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | A | 83.43 | 7,000 | 584,010 | 7,000 | |
Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Payment of Exercise | F | 80.34 | 376 | 30,208 | 15,247 | 15.6 K to 15.2 K (-2.41 %) |
Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Grant | A | 0.00 | 3,570 | 0 | 15,623 | 12.1 K to 15.6 K (+29.62 %) |
Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Option Exercise | A | 83.43 | 36,280 | 3,026,840 | 36,280 | |
Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Grant | A | 0.00 | 16,190 | 0 | 63,072 | 46.9 K to 63.1 K (+34.53 %) |
Mar 16 2016 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Sell | S | 86.21 | 1,996 | 172,079 | 76,190 | 78.2 K to 76.2 K (-2.55 %) |
Mar 07 2016 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Gift | G | 0.00 | 2,191 | 0 | 82,269 | 80.1 K to 82.3 K (+2.74 %) |
Mar 07 2016 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Gift | G | 0.00 | 2,191 | 0 | 69,448 | 71.6 K to 69.4 K (-3.06 %) |
Mar 07 2016 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Payment of Exercise | F | 89.57 | 2,395 | 214,520 | 71,639 | 74 K to 71.6 K (-3.24 %) |
Mar 07 2016 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Gift | G | 0.00 | 45,727 | 0 | 80,078 | 34.4 K to 80.1 K (+133.12 %) |
Mar 07 2016 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Gift | G | 0.00 | 45,727 | 0 | 74,034 | 119.8 K to 74 K (-38.18 %) |
Mar 07 2016 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Gift | G | 0.00 | 2,675 | 0 | 34,351 | 31.7 K to 34.4 K (+8.44 %) |
Mar 07 2016 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Gift | G | 0.00 | 2,675 | 0 | 119,761 | 122.4 K to 119.8 K (-2.18 %) |
Mar 07 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 89.57 | 8,989 | 805,145 | 331,511 | 340.5 K to 331.5 K (-2.64 %) |
Mar 07 2016 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Payment of Exercise | F | 89.57 | 2,395 | 214,520 | 47,293 | 49.7 K to 47.3 K (-4.82 %) |
Mar 07 2016 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Sell | S | 88.42 | 1,255 | 110,970 | 46,882 | 48.1 K to 46.9 K (-2.61 %) |
Mar 07 2016 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Payment of Exercise | F | 89.57 | 2,395 | 214,520 | 48,137 | 50.5 K to 48.1 K (-4.74 %) |
Mar 07 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Payment of Exercise | F | 89.57 | 3,043 | 272,562 | 100,876 | 103.9 K to 100.9 K (-2.93 %) |
Mar 02 2016 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Payment of Exercise | F | 81.87 | 47,273 | 3,870,241 | 122,436 | 169.7 K to 122.4 K (-27.86 %) |
Mar 07 2016 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Payment of Exercise | F | 89.57 | 2,180 | 195,263 | 78,186 | 80.4 K to 78.2 K (-2.71 %) |
Mar 02 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 84.24 | 2,828 | 238,217 | 340,500 | 343.3 K to 340.5 K (-0.82 %) |
Mar 02 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 84.22 | 2,151 | 181,152 | 343,328 | 345.5 K to 343.3 K (-0.62 %) |
Mar 02 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 84.33 | 5,021 | 423,400 | 345,479 | 350.5 K to 345.5 K (-1.43 %) |
Mar 02 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 81.87 | 192,982 | 15,799,436 | 350,500 | 543.5 K to 350.5 K (-35.51 %) |
Mar 02 2016 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 86.12 | 4,623 | 398,120 | 49,688 | 54.3 K to 49.7 K (-8.51 %) |
Mar 02 2016 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Payment of Exercise | F | 81.87 | 46,766 | 3,828,732 | 54,311 | 101.1 K to 54.3 K (-46.27 %) |
Mar 02 2016 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Payment of Exercise | F | 81.87 | 17,656 | 1,445,497 | 80,366 | 98 K to 80.4 K (-18.01 %) |
Mar 02 2016 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Payment of Exercise | F | 81.87 | 17,656 | 1,445,497 | 50,532 | 68.2 K to 50.5 K (-25.89 %) |
Mar 02 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Payment of Exercise | F | 81.87 | 56,464 | 4,622,708 | 103,919 | 160.4 K to 103.9 K (-35.21 %) |